Back to results
US 2026/0000693 A1Published application
Serotonergic psychedelic agent for treating selective mutism
AssigneeLobe Sciences Ltd.
InventorsLyl TOMLINSON, Frederick SANCILIO, Maghsoud DARIANI
Life of this patent
Estimating the term…
Abstract
Methods and compositions for treating or alleviating symptoms of selective mutism in a human subject with a serotonergic psychedelic agent alone or in combination with N-acetylcysteine are provided.
Claims11
A method for alleviating one or more symptoms of selective mutism (SM) in a human, said method comprising administering to a human suffering from SM a serotonergic psychedelic agent.
A composition comprising a serotonergic psychedelic agent in an amount effective in alleviating one or more symptoms of SM.
Dependencies are inferred from the claim text.